HOME › DRUGS › BECLOMETASONE;FORMOTEROL
ACTIVE SUBSTANCE / INN

BECLOMETASONE;FORMOTEROL

Brand name(s): Riarify (previously CHF 5993 Chiesi Farmaceutici S.p.A.)
EMA LISTED
WITHDRAWN
Pulmonary Disease, Chronic Obstructive
ACTIVE SUBSTANCE
Beclometasone;Formoterol
REGULATORS
EMA
SPONSORS / MAH
Chiesi Farmaceutici S.p.A.
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
Riarify (previously CHF 5993 Chiesi Farmaceutici S.p.A.)Chiesi Farmaceutici S.p.A.Withdrawn23/04/2018Pulmonary Disease, Chronic Obstructive

FULL INTELLIGENCE ON BECLOMETASONE;FORMOTEROL

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →